1. Metabolic Enzyme/Protease MAPK/ERK Pathway
  2. Endogenous Metabolite p38 MAPK
  3. 7-Ketocholesterol

7-Ketocholesterol is an oxidation product of cholesterol, widely present in atherosclerotic plaques, and has a stronger atherogenic effect than cholesterol. 7-Ketocholesterol can inhibit the rate-limiting enzymes involved in bile acid and cholesterol synthesis, such as cholesterol 7α-hydroxylase and HMG-CoA reductase. 7-Ketocholesterol exhibits pro-inflammatory effects both in vivo and in vitro and can induce cell apoptosis (apoptosis).

For research use only. We do not sell to patients.

CAS No. : 566-28-9

Size Price Stock Quantity
Free Sample (0.1 - 0.2 mg)   Apply Now  
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
In-stock
Solution
10 mM * 1 mL in DMSO In-stock
Solid
5 mg In-stock
10 mg In-stock
25 mg In-stock
50 mg In-stock
100 mg In-stock
200 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 5 publication(s) in Google Scholar

Other Forms of 7-Ketocholesterol:

Top Publications Citing Use of Products

    7-Ketocholesterol purchased from MedChemExpress. Usage Cited in: Nano Today. 2025 Oct.

    Confocal fluorescence images and quantitative fluorescence analysis of the RAW264.7 cells incubated with fluorescently labeled 7-Ketocholesterol /Chol-doped BPSNs after siRNA knockdown of receptors (CD36, LOX-1, MSR1, and LDLR). Scale bar: 20 μm.

    7-Ketocholesterol purchased from MedChemExpress. Usage Cited in: Cell Death Discov. 2025 Jul 23;11(1):338.  [Abstract]

    We also confirmed that the infiltration of M2 macrophages induced by RBM17-OE can be inhibited by T-CA inhibitors (7-Ketocholesterol, 10 μM, 24 h) in vivo experiment.

    7-Ketocholesterol purchased from MedChemExpress. Usage Cited in: Cell Death Discov. 2025 Jul 23;11(1):338.  [Abstract]

    Comparing the effects of siHACD3 and 7-Ketocholesterol on serum FFA concentration in mice through in vivo experiments. Data was analyzed using t-tests. ns represents no significant difference.

    View All Endogenous Metabolite Isoform Specific Products:

    View All p38 MAPK Isoform Specific Products:

    • Biological Activity

    • Purity & Documentation

    • References

    • Customer Review

    Description

    7-Ketocholesterol is an oxidation product of cholesterol, widely present in atherosclerotic plaques, and has a stronger atherogenic effect than cholesterol. 7-Ketocholesterol can inhibit the rate-limiting enzymes involved in bile acid and cholesterol synthesis, such as cholesterol 7α-hydroxylase and HMG-CoA reductase. 7-Ketocholesterol exhibits pro-inflammatory effects both in vivo and in vitro and can induce cell apoptosis (apoptosis)[1].

    IC50 & Target

    Human Endogenous Metabolite

     

    Cellular Effect
    Cell Line Type Value Description References
    ARPE-19 IC50
    32.3 μM
    Compound: 4
    Cytotoxicity against human ARPE19 cells assessed as cell viability after 48 hrs by alamar blue assay
    Cytotoxicity against human ARPE19 cells assessed as cell viability after 48 hrs by alamar blue assay
    [PMID: 21797280]
    C6 IC50
    20 μM
    Compound: 7KC
    Growth inhibition of rat C6 cells after 24 hrs by trypan blue-based cell counting method
    Growth inhibition of rat C6 cells after 24 hrs by trypan blue-based cell counting method
    [PMID: 24211631]
    HEK293 EC50
    8.7 μM
    Compound: 9
    Binding affinity to FLAG/tGFP-tagged NPC1 I1061T mutant (unknown origin) expressed in HEK293 cells assessed as localization after 24 hrs by fluorescence microscopy
    Binding affinity to FLAG/tGFP-tagged NPC1 I1061T mutant (unknown origin) expressed in HEK293 cells assessed as localization after 24 hrs by fluorescence microscopy
    [PMID: 24928400]
    HEK293 EC50
    9.7 μM
    Compound: 6
    Binding affinity to human GFP-tagged NPC1L1 L1072T/L1168I mutant expressed in HEK293 cells assessed as localization to endoplasmic reticulum and plasma membrane after 24 hrs by fluorescence microscopic analysis
    Binding affinity to human GFP-tagged NPC1L1 L1072T/L1168I mutant expressed in HEK293 cells assessed as localization to endoplasmic reticulum and plasma membrane after 24 hrs by fluorescence microscopic analysis
    [PMID: 23830695]
    HT-29 IC50
    25.7 μM
    Compound: 4
    Cytotoxicity against human HT-29 cells assessed as cell viability after 48 hrs by alamar blue assay
    Cytotoxicity against human HT-29 cells assessed as cell viability after 48 hrs by alamar blue assay
    [PMID: 21797280]
    HT-29 IC50
    25.7 μM
    Compound: 6
    Cytotoxicity against human HT-29 cells after 48 hrs by Alamar blue assay
    Cytotoxicity against human HT-29 cells after 48 hrs by Alamar blue assay
    [PMID: 20931970]
    Vero IC50
    75 μM
    Compound: 1
    Cytotoxicity against african green monkey Vero cells by tetrazolium dye reduction assay
    Cytotoxicity against african green monkey Vero cells by tetrazolium dye reduction assay
    [PMID: 24084159]
    In Vitro

    7-Ketocholesterol (50 μM, 2.5-2 hours) can enhance leukocyte-endothelial cell adhesion via the p38 MAPK pathway[4].
    7-Ketocholesterol (2.5-40 μg/mL, 24 hours) induces apoptosis in a dose-dependent manner by activating caspase-3/7, -8, and -12 in human microvascular endothelial cells[5].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Western Blot Analysis[4]

    Cell Line: Human umbilical vein endothelial cells (HUVECs)
    Concentration: 50 μM
    Incubation Time: 0.5-2 h
    Result: Stimulated the phosphorylation of p38 MAPK, reaching a peak within 30-120 minutes, with no significant effect on JNK.
    Enhanced the adhesion of THP-1 cells to HUVECs and upregulated the expression of E-selectin.
    Promoted the expression of E-selectin by activating the transcription factor ATF-2.

    Cell Viability Assay[5]

    Cell Line: Human umbilical vein endothelial cells (HUVECs)
    Concentration: 2.5, 5, 10, 15, 20, 40 μg/mL
    Incubation Time: 24 h
    Result: The average cell viability of HMVEC cells treated with 7-Ketocholesterol at concentrations of 40, 20, 10, 5, and 2.5 μg/ml for 24 hours was 45.33%, 72.83% (p < 0.001), 82.7% (p < 0.05), 88.47%, and 88.5% (p > 0.05), respectively, while the untreated control was 88.83%.
    In Vivo

    7-Ketocholesterol (5-20 mg/mL, administered via biodegradable wafers implanted into the anterior chamber of rats' eyes, single dose) exhibited pro-angiogenic and pro-inflammatory effects in Brown Norway rats[1].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Model: Brown Norway rats (150-200 g)[3]
    Dosage: 5, 10, 15, 20 mg/mL
    Administration: Implanting biodegradable wafers containing 7-Ketocholesterol into the anterior chamber of rats' eyes, single dose
    Result: Significantly increased angiogenesis, with a large infiltration of macrophages detected by immunohistochemistry.
    Promoted the growth of new blood vessels originating from the limbus and extending through the cornea, peaking between days 7 and 10 after implantation.
    Led to a marked increase in vascular endothelial growth factor (VEGF), IL-1b, and GRO/KC in the aqueous humor.
    Molecular Weight

    400.64

    Formula

    C27H44O2

    CAS No.
    Appearance

    Solid

    Color

    Off-white to light yellow

    SMILES

    C[C@]1(CC2)[C@](CC[C@]1([H])[C@H](C)CCCC(C)C)([H])[C@@](C(C=C3C[C@H]4O)=O)([H])[C@@]2([H])[C@]3(CC4)C

    Structure Classification
    Initial Source
    Shipping

    Room temperature in continental US; may vary elsewhere.

    Storage

    -20°C, protect from light

    *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

    Solvent & Solubility
    In Vitro: 

    Ethanol : 25 mg/mL (62.40 mM; Need ultrasonic)

    DMSO : 6.06 mg/mL (15.13 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 2.4960 mL 12.4800 mL 24.9601 mL
    5 mM 0.4992 mL 2.4960 mL 4.9920 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start)

    C1

    ×
    Volume (start)

    V1

    =
    Concentration (final)

    C2

    ×
    Volume (final)

    V2

    In Vivo:

    Select the appropriate dissolution method based on your experimental animal and administration route.

    For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
    To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

      Solubility: ≥ 0.62 mg/mL (1.55 mM); Clear solution

      This protocol yields a clear solution of ≥ 0.62 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (6.2 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

      Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
    • Protocol 2

      Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

      Solubility: ≥ 0.61 mg/mL (1.52 mM); Clear solution

      This protocol yields a clear solution of ≥ 0.61 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (6.1 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

      Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Please enter your animal formula composition:
    %
    DMSO +
    +
    %
    Tween-80 +
    %
    Saline
    Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
    The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
    Calculation results:
    Working solution concentration: mg/mL
    Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).

    *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

    The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
    Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
     If the continuous dosing period exceeds half a month, please choose this protocol carefully.
    Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
    Purity & Documentation

    Purity: 99.87%

    References

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    DMSO / Ethanol 1 mM 2.4960 mL 12.4800 mL 24.9601 mL 62.4002 mL
    5 mM 0.4992 mL 2.4960 mL 4.9920 mL 12.4800 mL
    10 mM 0.2496 mL 1.2480 mL 2.4960 mL 6.2400 mL
    15 mM 0.1664 mL 0.8320 mL 1.6640 mL 4.1600 mL
    Ethanol 20 mM 0.1248 mL 0.6240 mL 1.2480 mL 3.1200 mL
    25 mM 0.0998 mL 0.4992 mL 0.9984 mL 2.4960 mL
    30 mM 0.0832 mL 0.4160 mL 0.8320 mL 2.0800 mL
    40 mM 0.0624 mL 0.3120 mL 0.6240 mL 1.5600 mL
    50 mM 0.0499 mL 0.2496 mL 0.4992 mL 1.2480 mL
    60 mM 0.0416 mL 0.2080 mL 0.4160 mL 1.0400 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

     

    Requested Quantity *

    Applicant Name *

     

    Salutation

    Email Address *

     

    Phone Number *

    Department

     

    Organization Name *

    City

    State

    Country or Region *

         

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    7-Ketocholesterol
    Cat. No.:
    HY-113342
    Quantity:
    MCE Japan Authorized Agent: